How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

US Sector Rotation Strategy: Using the Business Cycle & RRG Charts to Find Market Leaders Read what the experts are trading this weekExclusive analysis from FXEmpire top analysts — curated insights ...

June 14, 2026 • On this week’s edition of In Black America, producer and host John L. Hanson, Jr. speaks with Donald Cravins, Jr. president and CEO of The National Minority Supplier Development ...